Erythema and scale in cutaneous lupus erythematosus significantly impacts patient quality of life and disease course impression.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 40314418.
- Also identified by DOI 10.1093/bjd/ljaf165 and PMC identifier 12360035.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Our study seeks to further characterize the impact of CLASI-A erythema and scale on patient quality of life in a larger multicentre cohort study. We found that both erythema and scale were associated with several PROMs, both at baseline and over time, most notably with patient impressions of disease progression. These findings justify the inclusion of erythema and scale in CLASI-A scoring and has important implications for future treatment directions, as no accepted measure of disease severity currently exists for cutaneous lupus erythematosus.